What to know ahead of Moderna-Merck cancer vaccine data reveal – USFTB

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54.

This is the online version of Adam’s Biotech Scorecard, a weekly newsletter featuring exclusive, spicy analysis on the biotech industry. Sign up here to get it delivered to your inbox.

It’s my first time in Madrid. What should I see, other than the inside of the convention center? STAT’s Europe correspondent and I will provide updates from the ESMO Congress there in the ESMO in 30 newsletter. Sign up here. 

The Moderna-Merck cancer vaccine data reveal is days away. Here’s what to expect

I left Boston last night and landed in Madrid this morning to report from the European Society for Medical Oncology Congress. I’ll be joined by my colleague Andrew Joseph, who arrived here on a shorter flight from London.